연구성과로 돌아가기

2024 연구성과별 연구자 정보 (382 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Jung, Y. Jung, Y 6 Soonchunhyang Univ, Dept Internal Med, Coll Med, Cheonan, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Lee, B. J. Lee, BJ 7 Korea Univ, Dept Internal Med, Coll Med, Seoul, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Yoon, H. Yoon, H 8 Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Kim, H. W. Kim, HW 9 Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Coll Med, Yangsan, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Lim, Y. J. Lim, YJ 10 Dongguk Univ, Ilsan Hosp, Dept Internal Med, Goyang, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Lee, H. S. Lee, HS 11 Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Lee, Y. J. Lee, YJ 12 Keimyung Univ, Sch Med, Dept Internal Med, Daegu, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Lee, J. Lee, J 13 Chosun Univ, Sch Med, Dept Internal Med, Gwangju, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Lee, C. K. Lee, CK 14 Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Shin, S. Y. Shin, SY 15 Chung Ang Univ, Gwangmyeong Hosp, Dept Internal Med, Gwangmyeong, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Moon, J. M. Moon, JM 16 Chung Ang Univ, Gwangmyeong Hosp, Dept Internal Med, Gwangmyeong, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Seo, J. Seo, J 17 Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study Choi, C. H. Choi, CH 18 Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with moderate-to-severe inflammatory bowel disease : a real-world data from a Korean multicentre prospective cohort study Kim, K. Kim, K 1 Chung Ang Univ Hosp, Dept Gastroenterol, Seoul, South Korea
Clinical efficacy and durability of subcutaneous infliximab in patients with moderate-to-severe inflammatory bowel disease : a real-world data from a Korean multicentre prospective cohort study Hong, S. N. H. Hong, SNH 2 Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Med, Seoul, South Korea
페이지 이동: